Torthaí cuardaigh - Skanda Moorthy

  • 1 - 1 toradh as 1 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery

    Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery de réir Sai Rahul Ponnana, Gauranga Mahalwar, Joris Holtrop, Steven H.J. Hageman, Tong Zhang, Santosh Kumar Sirasapalli, Skanda Moorthy, Zhuo Chen, Jean-Eudes Dazard, Sadeer Al-Kindi, Yakov Elgudin, Naveed Sattar, Sanjay Rajagopalan, Salil V. Deo

    Foilsithe / Cruthaithe 2025-09-01

    Background: Low-dose Colchicine therapy has demonstrated clinical benefit as secondary preventive therapy in patients with chronic coronary artery disease. While prior studies have reported its cost-effectiveness in this patient group, this has not yet been studied in post-coronary artery bypass gra...

    Cur síos iomlán

    Faigh an téacs iomlán
    Alt

    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: